Article
Author(s):
New York-A combination of hormonal therapy, brachytherapy, andexternal beam radiation has demonstrated excellent local control in high-riskprostate cancer patients.
Cleveland Clinic is First to Use Wireless, Catheter-Free Device to Monitor Bladder Dysfunction in Patients
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
Urologists discuss managing NMIBC amidst BCG shortages
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
NMIBC expert discussion emphasizes multidisciplinary collaboration
FDA accepts new drug application for zoliflodacin for uncomplicated gonorrhea
Adding cetrelimab to niraparib maintenance shows benefit in aggressive variant prostate cancer
Phase 2 trial of oncolytic immunotherapy launches in BCG-unresponsive NMIBC
Second-line cabozantinib shows efficacy in advanced renal cell carcinoma